Therapeutic activity of malononitrilamides (MNA 279 and MNA 715) on acute and chronic, relapsing, experimental, allergic encephalomyelitis (EAE)

Drugs under Experimental and Clinical Research

Volumn 23, Issue 5-6, 1997, Pages 175-181

  Schorlemmer, H U ^a   Bartlett, R R ^b  

^a Behringwerke AG   (Germany)

^b Werk Kalle Albert   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

2 CYANO 3 HYDROXY N [4 (TRIFLUOROMETHYL)PHENYL] 6 HEPTYNAMIDE; 2 CYANO N (4 CYANOPHENYL) 3 CYCLOPROPYL 3 OXOPROPIONAMIDE; IMMUNOSUPPRESSIVE AGENT; MYELIN BASIC PROTEIN; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE DURATION; DOSE RESPONSE; DRUG EFFICACY; FEMALE; IMMUNIZATION; INTRAGASTRIC DRUG ADMINISTRATION; MORTALITY; MOUSE; NONHUMAN; RAT; SENSITIZATION; SYMPTOM;

ACUTE DISEASE; ALKYNES; ANIMALS; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; GUINEA PIGS; IMMUNOSUPPRESSIVE AGENTS; ISOXAZOLES; MICE; MICE, INBRED STRAINS; NITRILES; RABBITS; RATS; RATS, INBRED LEW;

EID: 0031389857     PISSN: 03786501     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Levine S. Relationship of experimental allergic encephalomyelitis to human disease. Res. Pub. Assoc. Res. Nerv. Ment. Dis., 49, 33, 1971.
2. Mokhtarian F., McFarlin D.E., Raine C.S. Adoptive transfer of myelin basic protein sensitized T-cells produced chronic relapsing demyelinating disease in mice. Nature, 309, 356, 1984.
3. Hutinga J., van Roolgen N., de Grost C.J.A., Uitdehaag B.M.J., Dijkstra C.D. Suppression of experimental allergic encephalomyelitis in Lewis rats after elimination of macrophages. J. Exp. Med., 172, 1025, 1990.
4. Morris R.E., Huang X., Cao W., Zheng B., Shorthouse R.A. Leflunomide (HWA 486) and its analog suppress T-and B-cell proliferation in vitro, acute rejection, ongoing rejection, and antidonor antibody synthesis in mouse, rat, and cynomolgus monkey transplant recipients as well as arterial intimal thickening after balloon catheter injury. Transplant. Proc. 27, 445, 1995.
5. Schorlemmer H.U., Schwab W., Ruuth E., Kurrle R. Acute skin graft rejection can be prevented and treated in rat models by malononitrilamides. Transplant. Proc., 28, 3048, 1996.
6. Lin Y., Segers C., Waer M. Efficacy of the malononitrilamide X 920715 as compared to leflunomide in cardiac allo-and xenotransplantation in rats. Transplant. Proc., 28, 3036, 1996.
7. Schorlemmer H.U., Kurrle R. Control of mouse-to-rat skin xenograft rejection by malononitrilamides. Transplant. Proc., 28, 3037, 1996.
8. Williamson R.A., Yea C.M., Robson P.A., et al. Dehydroorotate dehydrogenase is a high affinity binding protein for A 771726 and mediator of a range of biological effects of the immunomodulatory compound. J. Biol. Chem., 270, 22467, 1995.
9. Kurrle R., Bartlett R.R., Lauffer L., Schorlemmer H.U. Malononitrilamides inhibit T-and B-cell responsiveness. Transplant. Proc., 28, 3053, 1996.
10. Kurrle R., Ruuth E., Bartlett R.R., Lauffer L., Schorlemmer H.U. Malononitrilamides inhibit T-and B-cell responsiveness in different species. Transplant. Proc., 29, 1302, 1997.
11. Schorlemmer H.U., Kurrle R., Bartlett R.R. Malononitrilamides inhibit the development of various murine graft-vs-host diseases. Transplant. Proc., 28, 3043, 1996.
12. Schorlemmer H.U., Brendel S., Bartlett R.R. Malononitrilamides prevent the development of murine systemic lupus erythematosus-like diseases in BDF1 hybrid mice and MRL/lpr autoimmune mice. Transplant. Proc., 28, 3040, 1996.
13. Schorlemmer H.U., Bartlett R.R., Kurrle R. Analogues of leflunomide's primary metabolite, the malononitrilamides, prevent the development of graft-versus-host disease. Transplant. Proc., 29, 1298, 1997.
14. Schorlemmer H.U., Dickneite G. Disease modifying activity of 15-deoxyspergualin on acute and chronic relapsing experimental allergic encephalomyelitis as models of multiple sclerosis (MS). Agents Actions, 41, C209, 1994.
15. Feurer C., Prentice D.E., and Camisuli S. Chronic relapsing experimental allergic encephalomyelitis in the Lewis rat. J. Neuroimmunol., 10, 159, 1985.
16. Baker D., O'Neill J.K., Gschmeissner S.E., Wilcox C.E., Butter C., Turk J.L. Induction of chronic relapsing experimental allergic encephalomyelitis in Biozzi mice. J. Neuroimmunol., 28, 261, 1990.
17. Schorlemmer H.U., Bartlett R.R. Therapeutic activity of lellunomide in acute and chronic relapsing experimental allergic encephalomyelitis. Agents Actions, 41, C271, 1994.